ivWatch, LLC

ivWatch, LLC Our mission is bold and clear: STOP IV HARM. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates.

ivWatch is redefining IV therapy safety with the only FDA-cleared and CE-marked medical device in the world designed to detect IV infiltrations and extravasations early, before they cause patient harm. ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.

At the heart of every treatment in children’s hospitals is the patient’s IV—where precision, vigilance, and care are par...
03/05/2026

At the heart of every treatment in children’s hospitals is the patient’s IV—where precision, vigilance, and care are paramount.

Our innovative technology is advancing IV therapy to protect the youngest patients, reduce complications, and help improve outcomes.

We’re proud to support clinicians on the frontlines of pediatric care, ensuring every child receives safe, effective treatment.

Stay tuned for updates from the heart of children’s hospitals—where we’re making a real difference, one IV at a time.

Hospitals track CLABSIs relentlessly through dashboards, penalties, and public reporting.Yet one of the most common caus...
03/04/2026

Hospitals track CLABSIs relentlessly through dashboards, penalties, and public reporting.

Yet one of the most common causes of preventable harm still happens quietly, peripheral IV infiltrations and extravasations (PIVIEs).

Not because they’re rare. Because no one is required to count them.

As central line use declines, risk has shifted to peripheral IVs—often delivering high-risk medications without standardized tracking or visibility.

What isn’t measured isn’t managed. Severe tissue injury isn’t inevitable.
Late detection is the problem.

The most dangerous harm in the hospital isn’t always the most visible—
it’s the one happening quietly because no one is watching.

Read more: https://www.ivwatch.com/2026/02/27/the-riskiest-silent-hac-in-the-hospital/

03/03/2026

Ever had a patient roll over on their IV or a child pull on their IV tubing?

This is a common infiltration when the catheter becomes dislodged from the vein.

What to expect:
• Fairly rapid onset of symptoms of all the infusing fluids leaking or pooling into the subcutaneous tissue.
• Flushing the IV with normal saline or aspirating for blood return will provide immediate indications of an infiltration.

We took a chance and brought visibility to IV injuries—sharing real images of devastating patient harm to spark an impor...
03/02/2026

We took a chance and brought visibility to IV injuries—sharing real images of devastating patient harm to spark an important conversation. At trade shows, we were asked to censor them. On social platforms, the content was flagged as “disturbing.”

But if IV infiltration remains hidden and underreported, how do we have an honest dialogue about patient safety? And more importantly—how do we advance meaningful solutions?

Progress starts with transparency.
We cannot improve what we are unwilling to confront.

Clinicians are advised to monitor chemotherapy infusions every 5 to 10 minutes due to the severe and potentially life-th...
02/26/2026

Clinicians are advised to monitor chemotherapy infusions every 5 to 10 minutes due to the severe and potentially life-threatening harm that can occur from an extravasation.

But how often is this reality? With continuous monitoring of 5 times per second, we offer a patients and clinicians peace of mind between periodic assessments.

Help give these patients one less thing to worry about and be an advocate towards detecting the inevitable.

Source from: https://pmc.ncbi.nlm.nih.gov/articles/PMC4734939/

At ivWatch, our mission is to help safeguard clinicians and their patients through innovative technology. This mini sens...
02/25/2026

At ivWatch, our mission is to help safeguard clinicians and their patients through innovative technology. This mini sensor is defined by accuracy, offering a smarter, safer approach to IV therapy.

Key Benefits Include:
•Advanced Monitoring: Continuously monitors the IV site, detecting extravasations early before visible signs are often present.
•Real-Time Alerts: Provides immediate notifications to healthcare providers, ensuring timely intervention.
•Enhanced Accuracy: Utilizes patented algorithms to deliver precise and predictive IV insights
•User-Friendly Interface: Easy to integrate into existing workflows, with intuitive controls that simplify checking IVs.
•Cost-Effective: Reduces the incidence of IV-related complications, leading to significant cost savings and reduced lengths of stay.

Learn more: https://www.ivwatch.com/tech-overview/

02/24/2026

We all have heard the term “difficult stick,” which is where the clinician has attempted multiple sticks before getting the catheter properly secured in the vessel. The problem here is that there is a high likelihood that there are one or more punctures on the opposing side of the vein, creating multiple areas for fluid to leak.

Warning:
· This can be a slow leaky infiltration and can be more difficult to identify early with physical symptoms. Symptoms will develop more slowly.
· A regular saline flush or blood return are not good indicators of infiltration as the catheter is still located in the vein.
· This is dangerous when running any vesicant medication which can be caustic to the tissue even in smaller amounts and cause significant necrosis, scarring, and nerve damage.

"I’ve been here since the earliest prototypes, and what distinguishes ivWatch from other technologies is not just innova...
02/23/2026

"I’ve been here since the earliest prototypes, and what distinguishes ivWatch from other technologies is not just innovation—it’s validation.

From our first FDA submission supported by Cincinnati Children’s clinical data to independent third-party studies confirming performance in real-world settings, we have built this technology on evidence. That foundation is what allows us to continue expanding the platform with confidence."

THE IV SAFETY MOVEMENT IS GAINING MOMENTUMThe energy at the 2026 IV Therapy Summit was unmistakable, as clinicians unite...
02/19/2026

THE IV SAFETY MOVEMENT IS GAINING MOMENTUM

The energy at the 2026 IV Therapy Summit was unmistakable, as clinicians united around a shared priority: preventing avoidable harm from infiltration and extravasation injuries.

Through stronger alignment with national standards and better support for frontline clinicians in early detection and intervention, IV safety is moving beyond discussion into action. What was once a local hospital priority is now embedded as an NHS standard. The transition from reactive response to proactive prevention marks a powerful and necessary shift in patient safety culture.

ivWatch isn’t just a product—it’s a long-term commitment.Beyond precision IV safety technology, our clinical experts pro...
02/18/2026

ivWatch isn’t just a product—it’s a long-term commitment.

Beyond precision IV safety technology, our clinical experts provide continuous, hands-on support to help facilities sustain and advance IV therapy quality over time. From education to workflow integration, we work alongside clinicians to drive lasting improvement.

Our support is tailored to each facility and includes:
• Superuser training
• In-service days
• Clinical rounding
• Educational workshops
• Digital learning modules
• Study days and staff development sessions

We’re here to elevate IV therapy standards, strengthen clinical confidence, and improve patient safety—today and long term.

For too long, IV safety has relied on “wait and see”—and patients pay the price. IV extravasation remains a persistent y...
02/17/2026

For too long, IV safety has relied on “wait and see”—and patients pay the price.

IV extravasation remains a persistent yet preventable source of harm across healthcare.

It’s time to challenge the status quo:
• Do infusion protocols match today’s clinical risks?
• Are nurses equipped with training that goes beyond outdated practices?
• Is continuous surveillance technology that detects IV failure before it’s visible put into practice?

Awareness isn’t enough. Prevention requires action.

It’s time to move forward—and stop IV extravasations before harm occurs.

Learn more about IV surveillance technology : https://www.ivwatch.com/tech-overview/

02/17/2026

EDUCATION ALERT!
Hear from expert Andrew Barton, Nurse Consultant in IV Therapy & Vascular Access and NIVAS Lead Nurse as he shared insights on the five causes of IV infiltration and extravasation—and why many clinicians aren’t aware of them. These hidden risks reinforce why education is critical.

At ivWatch, we’re committed to providing educational tools for clinicians because we’re on a mission to stop IV harm.

Read more about the causes:
https://www.ivwatch.com/2025/01/16/ivs-fail-too-often/

Address

700 Tech Center Parkway, Suite 300
Newport News, VA
23606

Opening Hours

Monday 8:30am - 6pm
Tuesday 8:30am - 6pm
Wednesday 8:30am - 6pm
Thursday 8:30am - 6pm
Friday 8:30am - 6pm

Website

Alerts

Be the first to know and let us send you an email when ivWatch, LLC posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to ivWatch, LLC:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

ivWatch, LLC is a medical device company focused on improving the safety and effectiveness of intravenous (IV) therapy. IV therapy is a basic yet critical component of care in hospital and outpatient settings, but it has a high failure rate. Continuous monitors exist to keep track of patients’ heart, blood oxygen levels and pulse rates. Until now, no technology has been available to continuously monitor the health of a patient’s IV site, and whether drugs or fluids are being delivered through the vein or leaking into the tissue. The ivWatch Model 400 is a FDA-cleared device to help clinicians monitor the status of a patient’s IV to aid in the early detection of peripheral IV infiltrations and extravasations. Through the use of non-invasive sensor technology, the ivWatch Model 400 can help reduce potentially serious medication dosing errors and associated patient harm from infiltration events. A continuously monitored peripheral IV also offers an alternative to more intrusive vascular access devices when medically indicated. Use of these devices has increased, but can also pose significant risk of harm to patients and greater cost and liability for hospitals. ivWatch has the potential to transform IV therapy by improving patient care and safety, and offering health care providers a much-needed, reliable and cost-effective solution for continuously monitoring peripheral IVs.